SI1197223T1 - - Google Patents

Info

Publication number
SI1197223T1
SI1197223T1 SI200030651T SI200030651T SI1197223T1 SI 1197223 T1 SI1197223 T1 SI 1197223T1 SI 200030651 T SI200030651 T SI 200030651T SI 200030651 T SI200030651 T SI 200030651T SI 1197223 T1 SI1197223 T1 SI 1197223T1
Authority
SI
Slovenia
Prior art keywords
retinopathy
angiotensin
treating
salt
development
Prior art date
Application number
SI200030651T
Other languages
English (en)
Inventor
Shizue Nakagawa
Yasutaka Nagisa
Hitoshi Ikeda
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of SI1197223T1 publication Critical patent/SI1197223T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200030651T 1999-04-28 2000-04-27 SI1197223T1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12149899 1999-04-28
PCT/JP2000/002766 WO2000066161A1 (en) 1999-04-28 2000-04-27 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
EP00921056A EP1197223B1 (en) 1999-04-28 2000-04-27 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy

Publications (1)

Publication Number Publication Date
SI1197223T1 true SI1197223T1 (cg-RX-API-DMAC7.html) 2005-08-31

Family

ID=14812676

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030651T SI1197223T1 (cg-RX-API-DMAC7.html) 1999-04-28 2000-04-27

Country Status (23)

Country Link
US (2) US7064141B1 (cg-RX-API-DMAC7.html)
EP (1) EP1197223B1 (cg-RX-API-DMAC7.html)
KR (1) KR100865059B1 (cg-RX-API-DMAC7.html)
CN (1) CN1172719C (cg-RX-API-DMAC7.html)
AT (1) ATE289204T1 (cg-RX-API-DMAC7.html)
AU (1) AU774799B2 (cg-RX-API-DMAC7.html)
BR (1) BR0010084A (cg-RX-API-DMAC7.html)
CA (1) CA2371554C (cg-RX-API-DMAC7.html)
CZ (1) CZ301913B6 (cg-RX-API-DMAC7.html)
DE (1) DE60018186T2 (cg-RX-API-DMAC7.html)
DK (1) DK1197223T3 (cg-RX-API-DMAC7.html)
ES (1) ES2233362T3 (cg-RX-API-DMAC7.html)
HU (1) HU226948B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01010923A (cg-RX-API-DMAC7.html)
NO (1) NO327446B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ514855A (cg-RX-API-DMAC7.html)
PL (1) PL196895B1 (cg-RX-API-DMAC7.html)
PT (1) PT1197223E (cg-RX-API-DMAC7.html)
RU (1) RU2239454C2 (cg-RX-API-DMAC7.html)
SI (1) SI1197223T1 (cg-RX-API-DMAC7.html)
SK (1) SK286859B6 (cg-RX-API-DMAC7.html)
WO (1) WO2000066161A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200108527B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2468827A1 (en) * 2001-12-03 2003-06-12 Takeda Chemical Industries, Ltd. Insulin resistance improving agents
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
TWI349549B (en) * 2003-04-15 2011-10-01 Sankyo Co Medicament for treatment of intraocular angiopoietic disease
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers
WO2006024092A1 (en) * 2004-08-31 2006-03-09 Newsouth Innovations Pty Limited Vegf inhibition
DK1814527T4 (da) * 2004-11-05 2020-12-07 Boehringer Ingelheim Int Dobbeltlagstablet omfattende telmisartan og amlodipin
RU2420280C2 (ru) * 2005-04-21 2011-06-10 Сантен Фармасьютикал Ко., Лтд Терапевтическое средство против кератоконъюнктивального расстройства
KR20080074128A (ko) * 2005-12-06 2008-08-12 산텐 세이야꾸 가부시키가이샤 각결막 장애 치료제
PT2124903T (pt) * 2007-03-28 2019-09-26 Takeda Pharmaceuticals Co Composição farmacêutica sólida compreendendo um derivado de benzimidazole-7-carboxilato e um agente de controlo de ph

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
DE4201554A1 (de) * 1992-01-22 1993-07-29 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
GB9110635D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma
GB9223860D0 (en) 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0789957A (ja) 1993-09-22 1995-04-04 Nissan Chem Ind Ltd ビフェニルメチルアミン誘導体
MX9603259A (es) * 1994-02-08 1997-03-29 Novartis Ag Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii.
JPH09210183A (ja) * 1996-01-31 1997-08-12 Suzuki Motor Corp 動力伝達装置
NZ332008A (en) * 1996-03-29 1999-05-28 Smithkline Beecham Corp Eprosartan dihydrate and a process for its production and formulation
PL193365B1 (pl) * 1996-04-05 2007-02-28 Takeda Pharmaceutical Kompozycja farmaceutyczna do zapobiegania lub zwalczania chorób związanych z angiotensyną II oraz zastosowanie związków do wytwarzania leku do zapobiegania lub zwalczania chorób związanych z angiotensyną II
TW416953B (en) * 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP0855392A3 (de) 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2294515C (en) * 1997-06-27 2007-08-28 Smithkline Beecham Corporation Eprosartan monohydrate
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
CA2299470C (en) * 1997-08-06 2010-01-26 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation
EP1058541B1 (en) 1998-03-04 2004-01-28 Takeda Chemical Industries, Ltd. Sustained-release preparation for aii antagonist, production and use thereof
EP1096932B1 (en) 1998-07-10 2007-08-29 Novartis Pharma AG Antihypertensive combination of valsartan and calcium channel blocker
FR2783422A1 (fr) 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
JP2000159671A (ja) 1998-12-01 2000-06-13 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
NZ514855A (en) 2004-01-30
ATE289204T1 (de) 2005-03-15
MXPA01010923A (es) 2002-06-21
EP1197223A1 (en) 2002-04-17
CA2371554A1 (en) 2000-11-09
BR0010084A (pt) 2002-01-15
CN1172719C (zh) 2004-10-27
CZ301913B6 (cs) 2010-07-28
AU774799B2 (en) 2004-07-08
EP1197223B1 (en) 2005-02-16
CA2371554C (en) 2009-06-09
KR20020015315A (ko) 2002-02-27
PL196895B1 (pl) 2008-02-29
EP1197223A4 (en) 2003-10-29
AU4143400A (en) 2000-11-17
HUP0200890A3 (en) 2002-12-28
US7064141B1 (en) 2006-06-20
DE60018186T2 (de) 2005-12-29
ZA200108527B (en) 2002-10-17
NO20015257D0 (no) 2001-10-26
HUP0200890A2 (hu) 2002-11-28
DE60018186D1 (de) 2005-03-24
HU226948B1 (en) 2010-03-29
ES2233362T3 (es) 2005-06-16
PT1197223E (pt) 2005-04-29
DK1197223T3 (da) 2005-05-30
CZ20013804A3 (cs) 2002-04-17
US20060189669A1 (en) 2006-08-24
NO327446B1 (no) 2009-06-29
KR100865059B1 (ko) 2008-10-23
WO2000066161A1 (en) 2000-11-09
PL350554A1 (en) 2002-12-16
SK15452001A3 (sk) 2002-04-04
SK286859B6 (sk) 2009-06-05
CN1348385A (zh) 2002-05-08
RU2239454C2 (ru) 2004-11-10
NO20015257L (no) 2001-10-26

Similar Documents

Publication Publication Date Title
GB9801690D0 (en) Therapeutic agents
AU2864002A (en) Compounds having fungicidal activity and processes to make and use same
MY134880A (en) Thiazolyl amide derivatives
DE69829846D1 (de) Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
MY126559A (en) Fungicidal 2-methoxybenzophenones
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
SI1699795T1 (sl) Substituirani 8-piri(mi)dinil-dihidrospiro-(cikloalkilamin)pirimido(1,2a) pirimidin-6-onski derivati
SI1197223T1 (cg-RX-API-DMAC7.html)
HUP0101958A3 (en) Enhancement oxazolidinone antibacterial agents activity by using arginine derivatives
SI1397366T1 (sl) Nov ligand za nikotinske acetilholinske receptorje, koristen v terapiji
AU2002349773A1 (en) 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof
ATE248822T1 (de) Partikel mit kontrollierter freisetzungsrate
BG104447A (en) Biphenylamidine derivatives
ZA9811715B (en) Aqueous insecticidal pour-on treatment.
GB2343832B (en) Biscuits for animals, especially horses
WO2003097585A3 (en) Amidoacetonitrile compounds
EP1043311A4 (en) BIPHENYLAMIDINE DERIVATIVES
DE60009319D1 (de) Substituierte n-phenyl-2-hydroxy-2-methyl-3,3,3-trifluorpropanamid-derivative zur erhöhung der pyruvatdehydrogenaseaktivität
ZA986971B (en) 4-Aminopyrrole (3,2-D) pyrimidines as neuropeptide Y receptor antagonists.
PL1619185T3 (pl) Pochodna 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepiny lub jej sól
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
ZA200408029B (en) Novel 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors.
PT1027891E (pt) Antagonista de neuropeptido y
WO2001011968A3 (en) Heterocyclic spiro compounds as pesticides
SI1086695T1 (en) Antiviral compositions comprising yohimbine as active principle